KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 26th Apr 2024 ABUS stock ended at $2.73. This is 0.368% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.21% from a day low at $2.71 to a day high of $2.77.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Feb 14, 2024 $2.91 $2.94 $2.88 $2.91 1 486 742
Feb 13, 2024 $2.76 $2.91 $2.76 $2.89 2 672 196
Feb 12, 2024 $2.78 $2.88 $2.76 $2.87 2 141 773
Feb 09, 2024 $2.57 $2.79 $2.56 $2.76 3 807 120
Feb 08, 2024 $2.56 $2.65 $2.34 $2.54 4 006 797
Feb 07, 2024 $2.46 $2.53 $2.39 $2.49 1 474 992
Feb 06, 2024 $2.36 $2.47 $2.35 $2.47 700 001
Feb 05, 2024 $2.34 $2.42 $2.33 $2.36 1 145 840
Feb 02, 2024 $2.37 $2.39 $2.27 $2.38 1 549 361
Feb 01, 2024 $2.40 $2.41 $2.36 $2.40 462 461
Jan 31, 2024 $2.46 $2.49 $2.37 $2.37 493 118
Jan 30, 2024 $2.54 $2.54 $2.43 $2.46 466 313
Jan 29, 2024 $2.38 $2.55 $2.36 $2.54 3 034 880
Jan 26, 2024 $2.39 $2.42 $2.36 $2.38 556 961
Jan 25, 2024 $2.35 $2.41 $2.33 $2.38 534 919
Jan 24, 2024 $2.44 $2.46 $2.35 $2.35 298 854
Jan 23, 2024 $2.39 $2.41 $2.36 $2.40 315 035
Jan 22, 2024 $2.39 $2.40 $2.33 $2.37 1 008 197
Jan 19, 2024 $2.34 $2.36 $2.29 $2.36 889 516
Jan 18, 2024 $2.29 $2.33 $2.22 $2.32 806 702
Jan 17, 2024 $2.24 $2.27 $2.21 $2.27 317 290
Jan 16, 2024 $2.34 $2.34 $2.24 $2.26 407 854
Jan 12, 2024 $2.40 $2.42 $2.30 $2.31 353 665
Jan 11, 2024 $2.40 $2.40 $2.31 $2.37 514 148
Jan 10, 2024 $2.46 $2.47 $2.40 $2.42 370 316
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT